219 related articles for article (PubMed ID: 3129220)
1. Assessment of two new therapies for peptic ulcer disease: omeprazole and the prostaglandin analogues.
McColl KE
Dig Dis; 1988; 6(2):65-75. PubMed ID: 3129220
[No Abstract] [Full Text] [Related]
2. [Gastroduodenal ulcer pathology and prostaglandins].
Bellanger J; Pointereau-Bellanger A
Ann Gastroenterol Hepatol (Paris); 1987 May; 23(3):129-34. PubMed ID: 3113323
[No Abstract] [Full Text] [Related]
3. Peptic ulcer disease, cytoprotection, and prostaglandins.
Fiske SC
Arch Intern Med; 1988 Oct; 148(10):2112-3. PubMed ID: 3140751
[No Abstract] [Full Text] [Related]
4. Side effects of anti-ulcer prostaglandins: an overview of the worldwide clinical experience.
Bianchi Porro G; Parente F
Scand J Gastroenterol Suppl; 1989; 164():224-9; discussion 229-31. PubMed ID: 2510273
[TBL] [Abstract][Full Text] [Related]
5. [Drug therapy of peptic ulcer. What is coming up?].
Müller P; Dammann HG; Simon B; Kommerell B
Leber Magen Darm; 1987 Feb; 17(1):50-4. PubMed ID: 3104707
[TBL] [Abstract][Full Text] [Related]
6. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; prostaglandins].
Arakawa T; Kobayashi K
Nihon Rinsho; 1988 Jan; 46(1):64-8. PubMed ID: 3131560
[No Abstract] [Full Text] [Related]
7. [Therapy and prevention of peptic lesions by prostaglandins].
Müller P; Dammann HG; Simon B
Z Gastroenterol; 1987 Aug; 25 Suppl 3():166-74. PubMed ID: 3116777
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin treatment for peptic ulcer.
Walt RP
Scand J Gastroenterol Suppl; 1988; 146():40-9. PubMed ID: 2906468
[TBL] [Abstract][Full Text] [Related]
9. A review of the therapeutic efficacy of misoprostol, a prostaglandin E1 analogue.
Nicholson PA
S Afr Med J; 1988 Jul; 74 Suppl():56-8. PubMed ID: 3133797
[No Abstract] [Full Text] [Related]
10. Efficacy of prostanoids in the treatment of gastric ulcer.
Rachmilewitz D
Clin Invest Med; 1987 May; 10(3):238-42. PubMed ID: 3113800
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandins and peptic ulcer therapy.
Walt RP
Scand J Gastroenterol Suppl; 1990; 174():29-36. PubMed ID: 1976271
[TBL] [Abstract][Full Text] [Related]
12. [Clinical experiences with misoprostol].
Herting RL; Nissen CH
Fortschr Med; 1986 Nov; 104(44):865-8. PubMed ID: 3100408
[No Abstract] [Full Text] [Related]
13. [Current directions in the treatment of gastric and duodenal ulcers].
Fellus R
Dakar Med; 1988; 33(1-4):42-4. PubMed ID: 2908566
[No Abstract] [Full Text] [Related]
14. The therapeutic efficacy of misoprostol in peptic ulcer disease.
Watkinson G; Hopkins A; Akbar FA
Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
[TBL] [Abstract][Full Text] [Related]
15. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.
Hawkey CJ; Karrasch JA; Szczepañski L; Walker DG; Barkun A; Swannell AJ; Yeomans ND
N Engl J Med; 1998 Mar; 338(11):727-34. PubMed ID: 9494149
[TBL] [Abstract][Full Text] [Related]
16. [Peptic ulcer. New H2 blockers, prostaglandins, benzimidazoles].
Gugler R
Fortschr Med; 1987 Apr; 105(10):197-201. PubMed ID: 3108126
[No Abstract] [Full Text] [Related]
17. [New developments in ulcer therapy: famotidine, omeprazole misoprostol].
Gugler R
Med Klin (Munich); 1986 Mar; 81(6):208-13. PubMed ID: 3097476
[No Abstract] [Full Text] [Related]
18. Misoprostol in peptic ulcer disease.
Watkinson G; Akbar FA
Prostaglandins; 1987; 33 Suppl():78-92. PubMed ID: 3122278
[TBL] [Abstract][Full Text] [Related]
19. Methyl-prostaglandin E2 analogues for healing of gastro-duodenal ulcers.
Rybicka J; Gibiński K
Scand J Gastroenterol; 1978; 13(2):155-9. PubMed ID: 345414
[TBL] [Abstract][Full Text] [Related]
20. Misoprostol.
Med Lett Drugs Ther; 1989 Mar; 31(787):21-2. PubMed ID: 2493124
[No Abstract] [Full Text] [Related]
[Next] [New Search]
